India Vaccine Maker Is Still Testing AstraZeneca’s Shot After Firm Halts Trials

(Bloomberg) -- The Indian company enlisted to manufacture a billion doses of AstraZeneca Plc’s experimental Covid-19 vaccine is pausing its own clinical trial, after earlier declaring it would push...